ListedSMEPharmaceuticals & DrugsAPPL

Aptus Pharma IPO

Aptus Pharma IPO is an SME IPO raising ₹13 Cr at ₹65 – ₹70 a share. It listed on 30 Sept 2025 at ₹81, +15.4% against its issue price of ₹70, and trades at ₹472 today (+1586.1% since issue, after adjusting for bonus issues or splits: one share allotted at the IPO is now 2.5 shares). It was subscribed 22× in total.

Get alerts on this company Company page Prospectus ↗

₹70

Issue price

₹472

Price now

+1586.1%

Since issue price

30 Sept 2025

Listed on

22×Subscribed (final) · all exchanges

22.2 times more demand than shares on offer

populated partly populated we hold nothing here — the tab says why

Terms of the issue

The mechanics of what is being sold. Held for every issue we track.

Price band₹65 – ₹70

Cut-off price₹70

Issue size₹13 Cr

Shares per lot2000

Minimum application₹1,40,000

Minimum quantity4000

Face value₹10

Listing exchangesBSE

ISININE15XJ01010

Bidding hours10:00 – 17:00 IST

Bidding window23 Sept 2025 – 25 Sept 2025

SME

What being an SME issue means here. SME issues list on NSE Emerge or BSE SME. They disclose less than mainboard issues, trade far more thinly, and — by regulation — the minimum application is a full lot worth roughly ₹1–1.5 lakh rather than about ₹15,000. That is why the minimum above is so much larger than for a mainboard issue.

Not here yet

Valuation against the issuer's named peers, what the fresh money funds, and the anchor-investor allocation come from reading the prospectus, which we do for current and upcoming issues — historical issues will not gain them.